This document describes the design and results of the validation exercise for the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay, organised by France and the United Kingdom. This method was developed for the detection of estrogen axis active substances. The project was on the Test Guidelines Programme work plan until 2024.
Validation report for the Test Guideline 252 on the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
18 December 2025265 Pages
-
15 December 2025169 Pages
-
Report3 December 2025136 Pages
-
Report3 December 202594 Pages
-
2 June 202540 Pages
-
28 May 202591 Pages
Related publications
-
2 July 2026115 Pages
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
2 July 202663 Pages -
Report
Assays addressing the Adverse Outcome Pathway Key Event on Keratinocyte activation
2 July 202698 Pages